Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
Worldwide, 50 million people suffer from dementia, a group of symptoms affecting cognitive and social functions, progressing severely enough to interfere with daily life. Alzheimer’s disease (AD) accounts for most of the dementia cases. Pathological and clinical findings have led to propos...
Main Authors: | Masaru Tanaka, Zsuzsanna Bohár, László Vécsei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/3/564 |
Similar Items
-
The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
by: Gábor Nagy-Grócz, et al.
Published: (2017-06-01) -
Corrigendum: The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
by: Gábor Nagy-Grócz, et al.
Published: (2020-09-01) -
Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus
by: Katalin Sas, et al.
Published: (2008-11-01) -
A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia
by: Alexandra Büki, et al.
Published: (2021-09-01) -
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
by: Tamás Biernacki, et al.
Published: (2020-06-01)